vs
CHAIN BRIDGE BANCORP INC（CBNA）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是CHAIN BRIDGE BANCORP INC的1.3倍（$19.6M vs $14.7M），CHAIN BRIDGE BANCORP INC净利率更高（36.4% vs -177.4%，领先213.8%），CHAIN BRIDGE BANCORP INC自由现金流更多（$11.5M vs $-23.1M）
该公司原为公开上市的多元化银行控股集团，总部位于芝加哥近郊，由杰拉尔德·菲茨杰拉德创立，菲茨杰拉德家族持有其多数股权。1994年，该公司被蒙特利尔银行合并收购，蒙特利尔银行旗下美国子公司哈里斯银行集团通过此次合并，扩大了哈里斯银行在芝加哥地区的业务布局，这笔全股票交易估值约2.46亿美元。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CBNA vs LAB — 直观对比
营收规模更大
LAB
是对方的1.3倍
$14.7M
净利率更高
CBNA
高出213.8%
-177.4%
自由现金流更多
CBNA
多$34.6M
$-23.1M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $19.6M |
| 净利润 | $5.3M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 45.6% | -168.5% |
| 净利率 | 36.4% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $0.81 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBNALAB
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.1M | $19.6M | ||
| Q2 25 | $12.6M | $21.8M | ||
| Q1 25 | $14.5M | $40.8M | ||
| Q3 24 | $16.7M | $22.1M | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | — | $45.5M | ||
| Q4 23 | — | $28.2M |
净利润CBNALAB
| Q4 25 | $5.3M | — | ||
| Q3 25 | $4.7M | $-34.7M | ||
| Q2 25 | $4.6M | $-33.5M | ||
| Q1 25 | $5.6M | $-26.0M | ||
| Q3 24 | $7.5M | $-26.9M | ||
| Q2 24 | — | $-45.7M | ||
| Q1 24 | — | $-32.2M | ||
| Q4 23 | — | $-19.8M |
毛利率CBNALAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% | ||
| Q4 23 | — | 47.6% |
营业利润率CBNALAB
| Q4 25 | 45.6% | — | ||
| Q3 25 | 44.9% | -168.5% | ||
| Q2 25 | 45.8% | -118.1% | ||
| Q1 25 | 48.4% | -80.8% | ||
| Q3 24 | 56.3% | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% |
净利率CBNALAB
| Q4 25 | 36.4% | — | ||
| Q3 25 | 35.8% | -177.4% | ||
| Q2 25 | 36.3% | -153.7% | ||
| Q1 25 | 38.6% | -63.8% | ||
| Q3 24 | 44.8% | -122.0% | ||
| Q2 24 | — | -203.3% | ||
| Q1 24 | — | -70.6% | ||
| Q4 23 | — | -70.2% |
每股收益（稀释后）CBNALAB
| Q4 25 | $0.81 | — | ||
| Q3 25 | $0.72 | $-0.09 | ||
| Q2 25 | $0.70 | $-0.09 | ||
| Q1 25 | $0.85 | $-0.07 | ||
| Q3 24 | $1.64 | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 | ||
| Q4 23 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $586.6M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $169.2M | $399.7M |
| 总资产 | $1.8B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBNALAB
| Q4 25 | $586.6M | — | ||
| Q3 25 | $395.7M | $129.4M | ||
| Q2 25 | $377.3M | $158.6M | ||
| Q1 25 | $629.2M | $150.9M | ||
| Q3 24 | $639.8M | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M | ||
| Q4 23 | — | $51.7M |
总债务CBNALAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M |
股东权益CBNALAB
| Q4 25 | $169.2M | — | ||
| Q3 25 | $163.1M | $399.7M | ||
| Q2 25 | $156.9M | $424.5M | ||
| Q1 25 | $151.5M | $454.6M | ||
| Q3 24 | $104.8M | $489.3M | ||
| Q2 24 | — | $510.3M | ||
| Q1 24 | — | $577.3M | ||
| Q4 23 | — | $-148.1M |
总资产CBNALAB
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | $539.6M | ||
| Q2 25 | $1.4B | $557.0M | ||
| Q1 25 | $1.7B | $579.6M | ||
| Q3 24 | $1.6B | $681.5M | ||
| Q2 24 | — | $708.7M | ||
| Q1 24 | — | $777.7M | ||
| Q4 23 | — | $323.1M |
负债/权益比CBNALAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $11.5M | $-23.1M |
| 自由现金流率自由现金流/营收 | 78.1% | -118.1% |
| 资本支出强度资本支出/营收 | 28.0% | 4.5% |
| 现金转化率经营现金流/净利润 | 2.92× | — |
| 过去12个月自由现金流最近4个季度 | $17.9M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CBNALAB
| Q4 25 | $15.6M | — | ||
| Q3 25 | $2.8M | $-22.2M | ||
| Q2 25 | $3.4M | $-20.7M | ||
| Q1 25 | $3.1M | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | — | $-62.5M | ||
| Q4 23 | — | $-14.1M |
自由现金流CBNALAB
| Q4 25 | $11.5M | — | ||
| Q3 25 | $2.5M | $-23.1M | ||
| Q2 25 | $2.5M | $-22.6M | ||
| Q1 25 | $1.4M | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M |
自由现金流率CBNALAB
| Q4 25 | 78.1% | — | ||
| Q3 25 | 18.7% | -118.1% | ||
| Q2 25 | 20.0% | -103.6% | ||
| Q1 25 | 9.8% | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% |
资本支出强度CBNALAB
| Q4 25 | 28.0% | — | ||
| Q3 25 | 2.5% | 4.5% | ||
| Q2 25 | 6.5% | 8.7% | ||
| Q1 25 | 11.6% | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% |
现金转化率CBNALAB
| Q4 25 | 2.92× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.55× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBNA
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
